- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 26, 2025 | 530.2M sh |
| Long Term Debt | Q1 2025 · Dec 28, 2024 | $1.83B |
| Long Term Debt | Q1 2025 · Mar 30, 2024 | $1.73B |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $251.49M |
| Cash And Equivalents | Q1 2025 · Mar 30, 2024 | $264.09M |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $2.32B |
| Current Liabilities | Q1 2025 · Mar 30, 2024 | $2.52B |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $7.54B |
| Total Liabilities | Q1 2025 · Mar 30, 2024 | $7.43B |
| Current Assets | Q1 2025 · Dec 28, 2024 | $3.31B |
| Current Assets | Q1 2025 · Mar 30, 2024 | $3.52B |
| Total Assets | Q1 2025 · Dec 28, 2024 | $9.81B |
| Total Assets | Q1 2025 · Mar 30, 2024 | $9.55B |
| Shares Diluted restated | Q1 2025 · Mar 30, 2024 | 542.64M sh |
| Stock Repurchased | Q1 2025 · Mar 30, 2024 | $117.84M |
| Dividends Paid | Q1 2025 · Mar 30, 2024 | $118.81M |
| Capex | Q1 2025 · Mar 30, 2024 | $157.2M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | $257.41M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $2.12B |
| Stockholders Equity | Q1 2025 · Dec 30, 2023 | $2.15B |
| Eps Diluted restated | Q1 2025 · Mar 30, 2024 | $0.37 |
| Eps Basic restated | Q1 2025 · Mar 30, 2024 | $0.37 |
| Sga Expense | Q1 2025 · Mar 30, 2024 | $853.44M |
| Net Income | Q1 2025 · Mar 30, 2024 | $198.17M |
| Operating Income | Q1 2025 · Mar 30, 2024 | $263.13M |
| Gross Profit | Q1 2025 · Mar 30, 2024 | $1.22B |
| Cost Of Revenue | Q1 2025 · Mar 30, 2024 | $2.17B |
| Revenue | Q1 2025 · Mar 30, 2024 | $3.39B |